ICD Function, Patient Population Claims Will Be Clarified By CDRH Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA is crafting a "functional indications" policy to help agency staff and implantable cardioverter defibrillator manufacturers clarify the devices' intended patient population
You may also be interested in...
FDA Issues Long-Planned Draft Guidance On Functional Indications For ICDs
Manufacturers who wish to describe the benefits of ICDs in a particular patient population in the device labeling must submit a PMA supplement to FDA with supporting data, according to a 1draft guidance
FDA Issues Long-Planned Draft Guidance On Functional Indications For ICDs
Manufacturers who wish to describe the benefits of ICDs in a particular patient population in the device labeling must submit a PMA supplement to FDA with supporting data, according to a 1draft guidance
Defibrillator Coverage Decision Will Weigh DEFINITE, COMPANION Trials
St. Jude Medical estimates the worldwide market for high-voltage cardiac rhythm management devices will approach $4.7 bil. by year-end, growing 20% over the 2003 level, based on published peer-reviewed studies and a potentially broader Medicare coverage policy